Advanced NanoBiomed Research,
Journal Year:
2023,
Volume and Issue:
3(12)
Published: Nov. 28, 2023
The
therapeutic
modes
of
cancers
have
been
profoundly
renovated
by
immunotherapies,
which
shown
extraordinary
treating
efficacy
in
certain
tumor
entities.
However,
the
majority
cancer
patients
not
profited
from
it
because
negative
effects
microenvironment
(TME)
on
human
innate
and/or
adaptive
immunity,
including
hypoxia,
acidification,
irregular
vasculature,
and
a
plethora
immunosuppressive
cells
small
molecules,
contribute
to
progression,
migration,
resistance
drug,
so
forth.
Accordingly,
is
feasible
enhance
immunotherapies
increase
patients’
survival
through
restructure
TME.
Herein,
mechanisms
reverberations
aforementioned
elements
are
concentrated
on,
latest
achievements
combined
technologies
that
demonstrated
effective
boosting
TME
modulation
enumerated.
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Nov. 29, 2023
Abstract
Traditional
Chinese
Medicines
(TCMs)
have
been
used
for
centuries
the
treatment
and
management
of
various
diseases.
However,
their
effective
delivery
to
targeted
sites
may
be
a
major
challenge
due
poor
water
solubility,
low
bioavailability,
potential
toxicity.
Nanocarriers,
such
as
liposomes,
polymeric
nanoparticles,
inorganic
nanoparticles
organic/inorganic
nanohybrids
based
on
active
constituents
from
TCMs
extensively
studied
promising
strategy
improve
achieve
higher
therapeutic
effect
with
fewer
side
effects
compared
conventional
formulations.
This
review
summarizes
recent
advances
in
nanocarrier-based
systems
types
TCMs,
including
terpenoids,
polyphenols,
alkaloids,
flavonoids,
quinones,
different
natural
sources.
covers
design
preparation
nanocarriers,
characterization,
vitro/vivo
evaluations.
Additionally,
this
highlights
challenges
opportunities
field
suggests
future
directions
research.
Nanocarrier-based
shown
great
improving
efficacy
serve
comprehensive
resource
researchers
field.
Graphical
abstract
Biomaterials Science,
Journal Year:
2024,
Volume and Issue:
12(7), P. 1662 - 1692
Published: Jan. 1, 2024
In
this
review,
we
have
summarized
the
common
self-assembled
mechanism
of
NSMs-based
SANDDSs.
Meanwhile,
potential
applications
for
cancer
treatment
and
future
development
prospects
are
also
prospected.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: April 1, 2024
Abstract
Background
Herbal
nanoparticles
are
made
from
natural
herbs/medicinal
plants,
their
extracts,
or
a
combination
with
other
nanoparticle
carriers.
Compared
to
traditional
herbs,
herbal
lead
improved
bioavailability,
enhanced
stability,
and
reduced
toxicity.
Previous
research
indicates
that
medicine
nanomaterials
rapidly
advancing
making
significant
progress;
however,
bibliometric
analysis
knowledge
mapping
for
currently
lacking.
We
performed
by
retrieving
publications
related
the
Web
of
Science
Core
Collection
(WoSCC)
database
spanning
2004
2023.
Data
processing
was
using
R
package
Bibliometrix,
VOSviewers,
CiteSpace.
Results
In
total,
1876
articles
were
identified,
originating
various
countries,
China
being
primary
contributing
country.
The
number
in
this
field
increases
annually.
Beijing
University
Chinese
Medicine,
Shanghai
Traditional
Saveetha
India
prominent
institutions
domain.
Journal
“International
Nanomedicine”
has
highest
publications.
authors
these
reached
8234,
Yan
Zhao,
Yue
Zhang,
Huihua
Qu
most
prolific
Zhao
frequently
cited
author.
“Traditional
medicine,”
“drug
delivery,”
“green
synthesis”
main
focal
points.
Themes
such
as
synthesis,”
“curcumin,”
“wound
healing,”
“carbon
dots”
may
represent
emerging
areas.
Conclusions
Our
study
findings
assist
identifying
latest
frontiers
hot
topics,
providing
valuable
references
scholars
investigating
role
nanotechnology
medicine.
Graphical
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(7), P. e28942 - e28942
Published: March 31, 2024
Ferroptosis
is
an
iron-dependent
programmed
cell
death
modality,
which
has
showed
great
potential
in
anticancer
treatment.
Photodynamic
therapy
(PDT)
widely
used
clinic
as
therapy.
PDT
combined
with
ferroptosis-promoting
been
found
to
be
a
promising
strategy
improve
anti-cancer
efficacy.
Fenton
reaction
ferroptosis
can
provide
oxygen
for
PDT,
and
produce
reactive
species
enhance
ferroptosis.
In
this
review,
we
briefly
present
the
importance
of
treatment,
mechanism
ferroptosis,
researches
on
induced
synergistic
effect
cancer
killing.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 9, 2024
Abstract
Homogeneous
distribution
and
adequate
accumulation
of
photosensitizer
in
tumor
are
essential
for
effective
photodynamic
therapy
(PDT).
However,
the
intricate
microenvironment
(TME)
often
poses
great
challenges
to
deep
penetration
retention
therapeutic
agents
tumor.
Moreover,
important
effect
PDT
induce
specific
antitumor
immune
response
is
impeded
by
multiple
immunosuppressive
mechanisms
within
TME.
Confronting
these
issues,
here
a
rationally
designed
nanosystem
(SUN‐NPA)
with
acid‐responsive
sphere‐to‐fiber
transformation
ability
leveraging
characters
drug
molecules
proposed
achieve
self‐delivery
Chlorin
e6
(Ce6)
two
small‐molecule
immunomodulators,
metformin
(MET)
sunitinib
(SUN).
The
spatiotemporal
controlled
enables
homogeneous
high
drugs
enduring
complete
elimination.
Meanwhile,
co‐delivered
MET
SUN
alleviate
immunosuppression
from
aspects,
effectively
synergizing
ignite
potent
host
long‐lasting
immunological
memory
against
cells.
artful
integration
enhanced
activated
immunity
realized
SUN‐NPA
leads
significant
inhibition
growth
metastasis,
exhibiting
potential
oncotherapy.
Acta Pharmaceutica Sinica B,
Journal Year:
2023,
Volume and Issue:
14(2), P. 765 - 780
Published: Oct. 19, 2023
A
major
challenge
facing
photodynamic
therapy
(PDT)
is
that
the
activity
of
immune-induced
infiltrating
CD8+
T
cells
subject
to
regulatory
lymphocytes
(Tregs),
leaving
tumor
at
risk
recurrence
and
metastasis
after
initial
ablation.
To
augment
antitumor
response
reprogram
immunosuppressive
microenvironment
(TME),
a
supramolecular
nanoparticle
(DACss)
constructed
by
host-guest
interaction
between
demethylcantharidin-conjugated
β-cyclodextrin
(DMC-CD)
amantadine-terminated
disulfide-conjugated
FFVLGGGC
peptide
with
chlorin
e6
decoration
(Ad-ss-pep-Ce6)
achieve
intelligent
delivery
photosensitizer
immunomodulator
for
breast
cancer
treatment.
The
acid-labile
β-carboxamide
bond
DMC-CD
hydrolyzed
in
acidic
TME,
resulting
localized
release
DMC
subsequent
inhibition
Tregs.
guest
molecule
Ad-ss-pep-Ce6
can
be
cleaved
high
level
intracellular
GSH,
reducing
toxicity
increasing
retention
tumor.
With
significant
increase
CTL/Treg
ratio,
combination
Ce6-based
PDT
DMC-mediated
immunomodulation
adequately
achieved
spatiotemporal
regulation
remodeling
as
well
improved
primary
situ
lung
suppression
aid
PD-1
antibody.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(20), P. 5043 - 5043
Published: Oct. 19, 2023
Ferroptosis
is
a
programmed
death
mode
that
regulates
redox
homeostasis
in
cells,
and
recent
studies
suggest
it
promising
of
tumor
cell
death.
regulated
by
iron
metabolism,
lipid
intracellular
reducing
substances,
which
the
mechanism
basis
its
combination
with
photodynamic
therapy
(PDT).
PDT
generates
reactive
oxygen
species
(ROS)
1O2
through
type
I
II
photochemical
reactions,
subsequently
induces
ferroptosis
Fenton
reaction
peroxidation
membrane
lipids.
kills
cells
generating
excessive
cytotoxic
ROS.
Due
to
limited
laser
depth
photosensitizer
enrichment,
systemic
treatment
effect
not
good.
Combining
can
compensate
for
these
shortcomings.
Nanoparticles
constructed
photosensitizers
agonists
are
widely
used
field
therapy,
their
targeting
biological
safety
be
improved
modification.
These
nanoparticles
only
directly
kill
but
also
further
exert
synergistic
activating
antitumor
immunity,
improving
hypoxia
microenvironment,
inhibiting
angiogenesis.
Ferroptosis-agonist-induced
chemotherapy
PDT-induced
ablation
have
good
clinical
application
prospects.
In
this
review,
we
summarize
current
research
progress
on
how
promote
each
other.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 10, 2024
Introduction
The
new
topical
formula
is
urgent
needed
to
meet
clinical
needs
for
majority
mild
patients
with
psoriasis.
Deucravacitinib
exerts
outstanding
anti-psoriatic
capacity
as
an
oral
TYK2
inhibitor;
however,
single
therapy
insufficient
target
the
complicated
psoriatic
skin,
including
excessive
reactive
oxygen
species
(ROS)
and
persistent
inflammation.
To
address
this
need,
engineered
smart
nano-therapeutics
hold
potential
delivery
of
deucravacitinib.
Methods
hydrophobic
was
loaded
into
polyethylene
glycol
block-polypropylene
sulphide
(PEG-b-PPS)
transdermal
in
treatment
oxidative
stress
model
HaCaT
psoriasis
established
by
TNF-α
IL-17A
vitro
.
JC-1
assay,
DCFH-DA
staining
mtDNA
copy
number
were
utilized
assess
mitochondrial
function.
0.75%
Carbopol
®
934
incorporated
SPMs
produce
hydrogels
Rhb
labeled
monitor
penetration
Immunofluorescence.
In
vivo
,
we
IMQ-induced
evaluate
therapeutic
effect
Car@Deu@PEPS.
Results
Deu@PEPS
exerted
effects
restoring
DNA
membrane
HaCaT.
Car@Deu@PEPS
supramolecular
micelle
had
longer
retention
time
dermis
ROS
microenvironment.
Topical
application
significantly
restored
normal
epidermal
architecture
skin
abrogation
splenomegaly
dermatitis
model.
inhibited
STAT3
signaling
cascade
a
corresponding
decrease
levels
differentiation
proliferative
markers
Keratin
17
Cyclin
D1,
respectively.
Meanwhile,
alleviated
generation
subsequent
NLRP3
inflammasome-mediated
pyroptosis.
Conclusion
prominent
anti-inflammatory
anti-oxidative
effects,
which
may
offers
more
patient-acceptable
fewer
adverse
compared
Biomacromolecules,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4991 - 5007
Published: Aug. 1, 2024
The
GPS-Nanoconveyor
(MA-NV@DOX-Cas13a)
is
a
targeted
nanoplatform
designed
for
the
imaging
and
gene/chemotherapy
synergistic
treatment
of
melanoma.
It
utilizes
rolling
circle
amplification
(RCA)
products
as
scaffold
to
construct
DNA
"Nanoconveyor"
(NV),
which
incorporates
multivalent
aptamer
(MA)
"GPS",
encapsulates
doxorubicin
(DOX)
in
transporter,
equips
it
with
CRISPR/Cas13a
ribonucleoproteins
(Cas13a
RNP).
Carrying
MA
enhances
ability
recognize
overexpressed
receptor
nucleolin
on
B16
cells,
enabling
precise
delivery
MA-NV@DOX-Cas13a
through
receptor-mediated
endocytosis.
activation
signal
transducer
activator
transcription
3
(STAT3)
cancer
cells
triggers
cis-cleavage
CRISPR/Cas13a,
initiating
its
trans-cleavage
function.
Additionally,
deoxyribonuclease
I
(DNase
I)
degrades
MA-NV,
releasing
DOX
intracellular
chemotherapeutic
agent.
Experiments
demonstrate
superior
capabilities
this
versatile
cellular
co-treatment
while
highlighting
advantages
these
nanodrug
systems
mitigating
side
effects.
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 28, 2025
Abstract
Pyroptosis‐immunotherapy
has
potential
for
triple‐negative
breast
cancer
treatment,
but
its
efficacy
is
limited
by
insufficient
pyroptosis
activation
and
the
need
phased,
balanced,
spatially
controlled
of
active
species
during
long‐term
treatment.
To
reconcile
intracellular/extracellular
demands
in
tumor
ablation,
a
nanoparticle‐hydrogel
hybrid
enabling
spatiotemporal
reactive
oxygen
(ROS)
modulation
engineered.
An
open‐shell
sonosensitizer
with
unpaired
electrons
molecular
orbitals
prepared
chelating
Cu
2
⁺
TCPP.
These
sonosensitizers
are
undergoing
bovine
serum
albumin
mediated
biomineralization
to
form
calcium
phosphate
particles
incorporated
into
an
injectable
hydrogel
through
Schiff
base
crosslinking
between
dopamine‐functionalized
oxidized
hyaluronic
acid
gallic
acid‐modified
chitosan.
After
intratumoral
injection,
nanoparticles
endocytosed
cells
undergo
acidic
degradation,
releasing
ions
GSH‐activatable
sonosensitizers.
Calcium
overload
synergizes
ultrasound‐mediated
oxidative
stress
induce
mitochondrial
damage
pyroptosis,
while
adhesive
hydrogels
retained
extracellular
matrix
control
excessive
secondary
ROS
levels
protect
oxidation‐sensitive
entities.
This
dual‐action
mechanism
enhances
overall
therapeutic
effect
combining
immediate
killing
immune
activation.
study
provides
new
route
material
design,
addressing
conflicting
short‐term
ablation
activation,
overcoming
limitations
current
pyroptosis‐based
immunotherapies.